Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
652-674
Author(s):
B. Rochat
Diverse Roles of GADD45α in Stress Signaling
Journal:
Current Protein & Peptide Science
Volume:
10
Page:
388-394
Author(s):
Ming Gao, Ning Guo, Chuanshu Huang and Lun Song
The Use of Intravenous Aminobisphosphonates for the Treatment of Pagets Disease of Bone
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
9
Page:
1052-1063
Author(s):
Luigi Gennari, Daniela Merlotti, Giuseppe Mossetti, Domenico Rendina, Vincenzo De Paola, Giuseppe Martini and Ranuccio Nuti
HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
9
Page:
1084-1101
Author(s):
Alvaro Marin-Hernandez, Juan C. Gallardo-Perez, Stephen J. Ralph, Sara Rodriguez-Enriquez and Rafael Moreno-Sanchez
Phosphodiesterase 3 (PDE3): Structure, Localization and Function
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
7
Page:
206-211
Author(s):
Taku Murata, Kasumi Shimizu, Kenichi Hiramoto and Toshiro Tagawa
ADAM28 as a Target for Human Cancers
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2349-2358
Author(s):
Satsuki Mochizuki and Yasunori Okada
Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising
Journal:
Current Drug Metabolism
Volume:
10
Page:
547-566
Author(s):
Guillermo Gervasini
Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Journal:
Current Drug Metabolism
Volume:
10
Page:
595-616
Author(s):
Snehasis Jana and Sandhya Mandlekar
Radiolabelled Peptides: Eon in Radiopharmaceutical
Journal:
Current Radiopharmaceuticals
Volume:
2
Page:
199-213
Author(s):
Vikash Kumar, Permender Rathee, Kanchan Kohli, Hema Chaudhary and Sushila Rathee
Advances in α(v)β(3) Integrin-Targeting Cancer Therapy and Imaging with Radiolabeled RGD Peptides
Journal:
Current Radiopharmaceuticals
Volume:
2
Page:
214-219
Author(s):
Petar M. Mitrasinovic